HealthEquity (NASDAQ:HQY) Releases FY 2025 Earnings Guidance

HealthEquity (NASDAQ:HQY) issued an update on its FY 2025 earnings guidance on Monday morning. The company provided earnings per share (EPS) guidance of 3.080-3.160 for the period, compared to the consensus estimate of 3.120. The company issued revenue guidance of $1.2 billion-$1.2 billion, compared to the consensus revenue estimate of $1.2 billion. HealthEquity also updated its FY 2026 guidance to EPS.

Wall Street Analyst Weigh In

Several analysts have issued reports on the company. The Goldman Sachs Group initiated coverage on HealthEquity in a research note on Friday, November 15th. They issued a “neutral” rating and a $108.00 price objective on the stock. BTIG Research lifted their price objective on shares of HealthEquity from $110.00 to $130.00 and gave the stock a “buy” rating in a research report on Thursday, November 14th. JMP Securities reiterated a “market outperform” rating and issued a $105.00 price objective on shares of HealthEquity in a report on Wednesday, September 4th. Royal Bank of Canada restated an “outperform” rating and set a $92.00 target price on shares of HealthEquity in a research note on Wednesday, September 4th. Finally, Barrington Research lifted their target price on shares of HealthEquity from $105.00 to $120.00 and gave the stock an “outperform” rating in a report on Monday, December 2nd. One investment analyst has rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. According to MarketBeat, HealthEquity presently has an average rating of “Moderate Buy” and a consensus target price of $109.64.

HealthEquity Price Performance

NASDAQ:HQY traded up $0.79 during trading hours on Monday, reaching $101.00. 1,201,665 shares of the company were exchanged, compared to its average volume of 628,101. The business has a 50 day moving average of $92.42 and a 200 day moving average of $83.64. HealthEquity has a 1-year low of $62.10 and a 1-year high of $105.82. The company has a debt-to-equity ratio of 0.51, a current ratio of 4.10 and a quick ratio of 4.10. The company has a market capitalization of $8.82 billion, a P/E ratio of 84.53, a P/E/G ratio of 1.57 and a beta of 0.55.

Insiders Place Their Bets

In other news, Director Frank Corvino sold 1,039 shares of the business’s stock in a transaction on Wednesday, November 6th. The stock was sold at an average price of $96.10, for a total transaction of $99,847.90. Following the completion of the transaction, the director now owns 3,784 shares of the company’s stock, valued at approximately $363,642.40. The trade was a 21.54 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Robert W. Selander sold 8,250 shares of the firm’s stock in a transaction dated Wednesday, October 9th. The shares were sold at an average price of $82.98, for a total value of $684,585.00. Following the completion of the sale, the director now directly owns 54,719 shares in the company, valued at $4,540,582.62. This trade represents a 13.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 10,536 shares of company stock worth $884,517 over the last ninety days. Corporate insiders own 2.20% of the company’s stock.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.